左心室辅助装置植入患者早期出血事件的发生率、预测因素及临床结局
研究连续纳入83例左心室辅助装置植入患者,随访11年,早期出血事件定义为出院前需胸部外科再探查或输注>4单位浓缩红细胞。47%患者发生早期出血事件,中位时间6天;植入前使用ECMO和植入后血小板减少是独立预测因素;发生早期出血者90天生存率显著更差(79% vs 96%,P=0.03)。
要点
- 83例左心室辅助装置植入患者中47%发生早期出血事件,中位时间6天
- 植入前ECMO支持者早期出血发生率92%,无ECMO支持者39%(P<0.001)
- 发生早期出血者90天生存率79%,未发生者96%(P=0.03)
核心结论
- 左心室辅助装置植入后需外科探查的早期出血事件发生率较高,尤其在以ECMO桥接及植入前后血小板减少的患者中。
研究设计与样本
- 连续纳入83例左心室辅助装置植入患者(年龄50±13岁,76%男性;77% HeartMate II,19% HeartMate 3),研究期11年。
- 早期出血事件定义为出院前需胸部外科再探查或输注>4单位浓缩红细胞。
主要发现
- 39例(47%)患者发生早期出血事件(年龄50±14岁,77%男性),中位时间6天(四分位距1-9天)。
- 14例植入前使用静脉-动脉体外膜氧合(ECMO)支持的患者中12例(92%)发生早期出血事件,69例无ECMO支持患者中27例(39%)发生(P<0.001)。
- HeartMate II与HeartMate 3之间早期出血率无差异。
- 多变量校正后,早期出血事件与植入前ECMO支持相关(比值比6.3,95%置信区间1.2-32.4;P=0.03),与植入后血小板减少(<150×10^9/L)相关(比值比5.9,95%置信区间1.9-18.7;P=0.002)。
- 发生早期出血事件的患者90天生存率显著低于未发生者(79% vs 96%,P=0.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bleeding is a common complication following left ventricular assist device (LVAD) implantation. The goal of this study was to investigate the incidence, predictors and clinical outcome of early bleeding events in patients after LVAD implantation. METHODS: A total of 83 patients (age 50 ± 13 years, 76% men) had an LVAD implanted [77% HeartMate II, 19% HeartMate 3 (Abbott, Chicago, IL, USA)] over a period of 11 years. Patients were included consecutively. An early bleeding event was defined as the need for thoracic surgical re-exploration or transfusion with >4 units of packed red blood cells before discharge. RESULTS: Overall, 39 (47%) patients (age 50 ± 14 years, 77% men) experienced an early bleeding event [median time 6 days (interquartile range 1-9 days)]. Furthermore, 10 (26%) of these patients had ≥2 bleeding events. Twelve of the 14 (92%) patients with venoarterial extracorporeal membrane oxygenation (ECMO) support before LVAD implantation experienced an early bleeding event versus 27 of the 69 (39%) patients without ECMO support (P < 0.001). No difference was found in early bleeding rates between HeartMate II and HeartMate 3. Predictors for early bleeding events were lower pre- and postimplant platelet counts and ECMO support preimplantation. After multivariable adjustment, early bleeding events were associated with ECMO support preimplantation (odds ratio 6.3, 95% confidence interval 1.2-32.4; P = 0.03) and thrombocytopenia (<150 × 109/l) postimplant (odds ratio 5.9, 95% confidence interval 1.9-18.7; P = 0.002). Patients who experienced an early bleeding event had a significantly worse 90-day survival rate compared to patients who did not (79% vs 96%, P = 0.03). CONCLUSIONS: An early bleeding event needing surgical exploration is highly prevalent after LVAD implantation, especially in patients bridged with ECMO and with pre- and postimplant thrombocytopenia.
引用
- Muslem R, Caliskan K, van Thiel R, et al. Incidence, predictors and clinical outcome of early bleeding events in patients undergoing a left ventricular assist device implant. Eur J Cardiothorac Surg. 2018. PMID: 29481654. doi:10.1093/ejcts/ezy044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。